BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4935067)

  • 1. The hospitalization proneness scale as a predictor of response to phenothiazine treatment. II. Delay of psychiatric hospitalization.
    Rosen B; Engelhart DM; Freedman N; Margolis R; Klein DF
    J Nerv Ment Dis; 1971 Jun; 152(6):405-11. PubMed ID: 4935067
    [No Abstract]   [Full Text] [Related]  

  • 2. The hospitalization proneness scale as a predictor of response to phenothiazine treatment.
    Rosen B; Engelhardt DM; Freedman N; Margolis R
    J Nerv Ment Dis; 1968 Jun; 146(6):476-80. PubMed ID: 5677025
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of psychiatric hospitalization. II. The Hospitalization Proneness Scale: a cross-validation.
    Rosen B; Engelhardt DM; Freedman N; Margolis R; Rudorfer L; Paley HM
    J Abnorm Psychol; 1972 Dec; 80(3):271-4. PubMed ID: 4639912
    [No Abstract]   [Full Text] [Related]  

  • 4. On the modification of paranoid symptomatology. II. Stylistic considerations and the effectiveness of phenothiazines.
    Freedman N; Cutler R; Engelhardt DM; Margolis R
    J Nerv Ment Dis; 1970 Jan; 150(1):68-76. PubMed ID: 4906641
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenothiazines in prevention of psychiatric hospitalization. IV. Delay or prevention of hospitalization--a reevaluation.
    Engelhardt DM; Rosen B; Freedman N; Margolis R
    Arch Gen Psychiatry; 1967 Jan; 16(1):98-101. PubMed ID: 5333777
    [No Abstract]   [Full Text] [Related]  

  • 6. Family interaction patterns, drug treatment, and change in social aggression.
    Cohen M; Freedman N; Engelhardt DM; Margolis RA
    Arch Gen Psychiatry; 1968 Jul; 19(1):50-6. PubMed ID: 5661009
    [No Abstract]   [Full Text] [Related]  

  • 7. On the modification of paranoid symptomatology.
    Freedman N; Cutler R; Engelhardt DM; Margolis R
    J Nerv Ment Dis; 1967 Jan; 144(1):29-36. PubMed ID: 5337100
    [No Abstract]   [Full Text] [Related]  

  • 8. Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines.
    Schooler NR; Boothe H; Goldberg SC
    Arch Gen Psychiatry; 1971 Aug; 25(2):138-47. PubMed ID: 5106102
    [No Abstract]   [Full Text] [Related]  

  • 9. PHENOTHIAZINES IN PREVENTION OF PSYCHIATRIC HOSPITALIZATION. 3. DELAY OR PREVENTION OF HOSPITALIZATION.
    ENGELHARDT DM; FREEDMAN N; ROSEN B; MANN D; MARGOLIS R
    Arch Gen Psychiatry; 1964 Aug; 11():162-9. PubMed ID: 14237612
    [No Abstract]   [Full Text] [Related]  

  • 10. PHENOTHIAZINES IN PREVENTION OF PSYCHIATRIC HOSPITALIZATION. II. DURATION OF TREATMENT EXPOSURE.
    ENGELHARDT DM; ROSEN B; FREEDMAN N; MANN D; MARGOLIS R
    JAMA; 1963 Dec; 186():981-3. PubMed ID: 14066719
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of response to phenothiazines in schizophrenia. A crossvalidation study.
    Goldberg SC; Frosch WA; Drossman AK; Schooler NR; Johnson GF
    Arch Gen Psychiatry; 1972 Apr; 26(4):367-73. PubMed ID: 4552130
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenothiazine intake and staff attitudes.
    Irwin DS; Weitzel WD; Morgan DW
    Am J Psychiatry; 1971 Jun; 127(12):1631-5. PubMed ID: 5565846
    [No Abstract]   [Full Text] [Related]  

  • 13. Chlorpromazine in women with chronic schizophrenia: the effect on cholesterol levels and cholesterol-behavior relationships.
    Clark ML; Ray TS; Paredes A; Ragland RE; Costiloe JP; Smith CW; Wolf S
    Psychosom Med; 1967; 29(6):634-42. PubMed ID: 5582955
    [No Abstract]   [Full Text] [Related]  

  • 14. Physician bias and the double-blind.
    Engelhardt DM; Margolis RA; Rudorfer L; Paley HM
    Arch Gen Psychiatry; 1969 Mar; 20(3):315-20. PubMed ID: 4884940
    [No Abstract]   [Full Text] [Related]  

  • 15. High dose trifluoperazine therapy in chronic schizophrenia.
    Prien RF; Levine J; Cole JO
    Am J Psychiatry; 1969 Sep; 126(3):305-13. PubMed ID: 4895559
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug and sociotherapy in the aftercare of schizophrenic patients. III. Adjustment of nonrelapsed patients.
    Hogarty GE; Goldberg SC; Schooler NR
    Arch Gen Psychiatry; 1974 Nov; 31(5):609-18. PubMed ID: 4374156
    [No Abstract]   [Full Text] [Related]  

  • 17. COMMUNICATION OF BODY COMPLAINTS AND PARANOID SYMPTOM CHANGE UNDER CONDITIONS OF PHENOTHIAZINE TREATMENT.
    FREEDMAN N; ENGELHARDT D; MANN D; MARGOLIS R; LONDON S
    J Pers Soc Psychol; 1965 Apr; 1():310-8. PubMed ID: 14328737
    [No Abstract]   [Full Text] [Related]  

  • 18. Group therapy and maintenance treatment of schizophrenics.
    Claghorn JL; Johnstone EE; Cook TH; Itschner L
    Arch Gen Psychiatry; 1974 Sep; 31(3):361-5. PubMed ID: 4606594
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent developments in the drug treatment of schizophrenia.
    Davis JM
    Am J Psychiatry; 1976 Feb; 133(2):208-14. PubMed ID: 766652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personality assessment and test interpretation of Mexican Americans: a critique.
    Padilla AM; Ruiz RA
    J Pers Assess; 1975 Apr; 39(2):103-9. PubMed ID: 1097629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.